UK Research Partnership Investment Fund

UK Research Partnership Investment Fund
Name	UK Research Partnership Investment Fund
Type	Grant fund
Founded	2012
Founder	Department for Business, Energy and Industrial Strategy, Higher Education Funding Council for England
Location	United Kingdom
Area served	England

Contents

UK Research Partnership Investment Fund is a capital grants scheme to support infrastructure for higher education research and innovation. The scheme was announced alongside strategic initiatives from Department for Business, Innovation and Skills, coordinated with bodies such as Research England, UK Research and Innovation, Innovate UK, Wellcome Trust and European Regional Development Fund partners. It aims to leverage capital investment from institutions like University of Cambridge, University of Oxford, Imperial College London and other Russell Group members to enhance research facilities across the United Kingdom.

Background and Purpose

The scheme was established following reviews by Wenham Review, discussions involving Treasury (HM Treasury), consultations with Office for Strategic Coordination of Health Research, and recommendations from bodies including Funding Council predecessors and the Kings College London research strategy teams. Its purpose aligned with national priorities set by the Industrial Strategy White Paper, the NHS England research agenda, and regional development plans from entities such as Greater London Authority, Scottish Government, Welsh Government and Northern Ireland Executive. The programme sought to stimulate collaboration among institutions such as University College London, Durham University, University of Manchester, University of Leeds and private partners like Siemens, AstraZeneca, GlaxoSmithKline and Rolls-Royce.

Administration has involved Research England, the Higher Education Funding Council for England legacy arrangements, and oversight by officials from Department for Business, Energy and Industrial Strategy and HM Treasury. Funding rounds were delivered through match-funded capital grants with contributions from universities, charitable foundations such as Wellcome Trust and Leverhulme Trust, philanthropic donors including Royal Society patrons and commercial partners like BT Group and Schneider Electric. Panels drawing expertise from Medical Research Council, Engineering and Physical Sciences Research Council, Arts and Humanities Research Council, and representatives from Russell Group and Universities UK oversee assessment and award, with periodic scrutiny from committees modelled on practices at Public Accounts Committee and National Audit Office.

Eligibility criteria emphasise capital works at research-intensive institutions including University of Birmingham, Newcastle University, University of Bristol, University of Southampton and University of Edinburgh. Projects typically involve laboratory construction, translational research hubs, precision manufacturing facilities, and shared equipment centres benefitting collaborations with organisations like NHS England, UK Research and Innovation, European Molecular Biology Laboratory and industry partners such as Pfizer and Unilever. Selection criteria assess impact on research capability, match funding sustainability, cross-institutional collaboration, and alignment with national priorities including programmes at Francis Crick Institute, Diamond Light Source, Hartree Centre and strategic themes from Science and Technology Facilities Council.

Awards have supported clusters of projects that enhanced capacities at Babraham Institute, Sanger Institute, Oxford University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus and regional innovation zones like Manchester Science Park and Oxford Science Park. Reported outcomes include increased grant capture from bodies such as European Research Council, improved industry partnerships with firms including Johnson & Johnson and BP, and creation of translational pathways linked to NHS Foundation Trusts and devolved administrations. Metrics cited by programme evaluations reference strengthened doctoral training partnerships such as those involving Economic and Social Research Council consortia, spin-out formation similar to ventures from Imperial Innovations, and enhanced access to facilities like cryo-electron microscopy suites modeled on Diamond Light Source capabilities.

Critics from voices including Trade Union Congress, regional development advocates, and some university groups argued that allocations favoured established institutions such as University of Oxford and University of Cambridge over smaller institutions like Bath Spa University, Ravensbourne University London and newer post-1992 universities. Concerns raised by commentators in outlets aligned with debates on Higher Education Policy Institute and reports by think tanks such as Institute for Public Policy Research focused on regional imbalance, sustainability of matched funding, reliance on philanthropic donors like Gatsby Charitable Foundation, and the complexity of commercialisation pathways compared to examples from National Institute for Health Research. Audits pointed to challenges in delivery timelines, planning consents, and coordination with capital programmes at Network Rail and local authorities such as Liverpool City Council.

Category:Research funding in the United Kingdom